| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0304-4165(93)90082-J |
| P698 | PubMed publication ID | 8098956 |
| P2093 | author name string | A Engström | |
| U Hellman | |||
| A J Anderson | |||
| I García | |||
| A L Harvey | |||
| E Karlsson | |||
| D L Marshall | |||
| J R Martínez | |||
| A Aneiros | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bunodosoma granulifera | Q2464744 |
| P304 | page(s) | 86-92 | |
| P577 | publication date | 1993-05-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | A potassium channel toxin from the secretion of the sea anemone Bunodosoma granulifera. Isolation, amino acid sequence and biological activity | |
| P478 | volume | 1157 |
| Q64250356 | A Recurrent Motif: Diversity and Evolution of ShKT Domain Containing Proteins in the Vampire Snail |
| Q42281976 | A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. |
| Q38875246 | Analgesic compound from sea anemone Heteractis crispa is the first polypeptide inhibitor of vanilloid receptor 1 (TRPV1). |
| Q57615210 | BgK anemone toxin inhibits outward K+ currents in snail neurons |
| Q44483351 | Characterization of a novel gastropod toxin (6-bromo-2-mercaptotryptamine) that inhibits shaker K channel activity |
| Q40768802 | Characterization of a novel radiolabeled peptide selective for a subpopulation of voltage-gated potassium channels in mammalian brain |
| Q34303998 | Characterization of a potassium channel toxin from the Caribbean sea anemone Stichodactyla helianthus |
| Q28363715 | Characterization of two Bunodosoma granulifera toxins active on cardiac sodium channels |
| Q56607489 | Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone |
| Q45845930 | Cnidarian Toxins Acting on Voltage-Gated Ion Channels |
| Q26775013 | Computational Studies of Venom Peptides Targeting Potassium Channels |
| Q58160926 | Determination of theC-terminal form of an anemone toxin using capillary electrophoresis and mass spectrometry |
| Q50101625 | Dynamics of venom composition across a complex life cycle. |
| Q74240945 | Effects of a toxin from the mucus of the Caribbean sea anemone (Bunodosoma granulifera) on the ionic currents of single ventricular mammalian cardiomyocytes |
| Q32163357 | Genomic structure of a potassium channel toxin from Heteractis magnifica |
| Q74081000 | Isolation and amino acid sequences of two Kunitz-type protease inhibitors from the sea anemone Anthopleura aff. xanthogrammica |
| Q37162392 | K+ channel modulators for the treatment of neurological disorders and autoimmune diseases |
| Q93013693 | Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond |
| Q33882600 | Mapping the functional anatomy of BgK on Kv1.1, Kv1.2, and Kv1.3. Clues to design analogs with enhanced selectivity |
| Q34263269 | Modulation of neuronal sodium channels by the sea anemone peptide BDS-I. |
| Q48068955 | Muscarinic toxins from the black mamba Dendroaspis polylepis |
| Q34424497 | Novel polypeptide toxins with crab lethality from the sea anemone Anemonia erythraea |
| Q58866916 | Partial sequence and toxic effects of granulitoxin, a neurotoxic peptide from the sea anemone Bunodosoma granulifera |
| Q41478126 | Pharmacology of potassium channels. |
| Q34470438 | Primary structure of a potassium channel toxin from the sea anemone Actinia equina |
| Q47714673 | Proteomic Analyses of the Unexplored Sea Anemone Bunodactis verrucosa. |
| Q30832013 | Purification, characterization and biosynthesis of parabutoxin 3, a component of Parabuthus transvaalicus venom |
| Q26825180 | Sea anemone (Cnidaria, Anthozoa, Actiniaria) toxins: an overview |
| Q27732602 | Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone |
| Q59093749 | Strategy for rapid immobilization of prey by a fish-hunting marine snail |
| Q33900937 | Structural basis for the biological activity of dendrotoxin-I, a potent potassium channel blocker |
| Q38659535 | Treating autoimmune disorders with venom-derived peptides |
| Q31425876 | Twenty years of dendrotoxins |
Search more.